{"disease":{"id":"viral-hepatitis","name":"viral hepatitis"},"drugs":{"marketed":[{"drug_id":"interferon-alfa-2b","indication_name":"Chronic type B viral hepatitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Intron A","generic_name":"INTERFERON ALFA-2B","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Interferon alpha","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"lamivudine","indication_name":"Chronic type B viral hepatitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Epivir","generic_name":"LAMIVUDINE","company_name":"GSK","drug_phase":"marketed","molecular_target":"Deoxycytidine kinase","drug_class":"Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]","quality_score":66,"revenue":null,"mechanism":"Epivir works by mimicking the building blocks of DNA to prevent the replication of viral genetic material."},{"drug_id":"adefovir-dipivoxil","indication_name":"Chronic type B viral hepatitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hepsera","generic_name":"ADEFOVIR DIPIVOXIL","company_name":"Gilead Sciences","drug_phase":"marketed","molecular_target":"DNA polymerase subunit gamma-1","drug_class":"Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor","quality_score":64,"revenue":null,"mechanism":"Hepsera works by mimicking a building block of DNA, which it uses to trick the Hepatitis B Virus into incorporating faulty genetic material, ultimately halting its replication."},{"drug_id":"peginterferon","indication_name":"Chronic type B viral hepatitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Peginterferon","company_name":"Ziv Hospital","drug_phase":"marketed","molecular_target":"Interferon alpha/beta receptor","drug_class":"Interferon beta [EPC]","quality_score":10,"revenue":null,"mechanism":null},{"drug_id":"viread","indication_name":"Chronic type B viral hepatitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Viread","company_name":"Replicor Inc.","drug_phase":"marketed","molecular_target":"Gag-Pol polyprotein, Reverse transcriptase/RNaseH","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"pegasys","indication_name":"Chronic type B viral hepatitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pegasys","company_name":"Zealand University Hospital","drug_phase":"marketed","molecular_target":"Interferon alpha/beta receptor","drug_class":"","quality_score":13,"revenue":null,"mechanism":null},{"drug_id":"clevudine","indication_name":"Chronic type B viral hepatitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Levovir","generic_name":"CLEVUDINE","company_name":"","drug_phase":"discontinued","molecular_target":"","drug_class":"clevudine","quality_score":null,"revenue":null,"mechanism":"Levovir works by inhibiting viral DNA synthesis, specifically targeting the hepatitis B virus."},{"drug_id":"adefovir","indication_name":"Chronic type B viral hepatitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ADEFOVIR","company_name":"","drug_phase":"discontinued","molecular_target":"DNA polymerase subunit gamma-1, Capsid protein, Protein P","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Adefovir is an antiviral medication used to treat chronic hepatitis B in adults and adolescents, with common side effects including fatigue, headache, and stomach pain."},{"drug_id":"sebivo","indication_name":"Chronic type B viral hepatitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Sebivo","company_name":"Ziv Hospital","drug_phase":"phase_1","molecular_target":"Capsid protein, Protein P","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"baraclude","indication_name":"Chronic type B viral hepatitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Baraclude","company_name":"Bristol-Myers Squibb","drug_phase":"marketed","molecular_target":"Capsid protein, Protein P, Protein P","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"entecavir","indication_name":"Chronic type B viral hepatitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Baraclude","generic_name":"ENTECAVIR","company_name":"Bristol-Myers Squibb","drug_phase":"marketed","molecular_target":"","drug_class":"entecavir","quality_score":70,"revenue":null,"mechanism":"Entecavir works by inhibiting the replication of the hepatitis B virus."},{"drug_id":"bulevirtide","indication_name":"Chronic viral hepatitis B with hepatitis D","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hepcludex","generic_name":"BULEVIRTIDE","company_name":"MYR GmbH","drug_phase":"marketed","molecular_target":"Sodium/bile acid cotransporter","drug_class":"","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"hepsera","indication_name":"Chronic type B viral hepatitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hepsera","company_name":"Gilead Sciences","drug_phase":"marketed","molecular_target":"DNA polymerase subunit gamma-1, Capsid protein, Protein P","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"peginterferon-alfa-2a","indication_name":"Chronic type B viral hepatitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pegasys","generic_name":"PEGINTERFERON ALFA-2A","company_name":"Hoffman-La Roche","drug_phase":"marketed","molecular_target":"Interferon alpha/beta receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":14,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04371276","title":"Seroepidemiology of Viral Hepatitis in Hong Kong","phase":"","overall_status":"COMPLETED","enrollment_count":2888,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT06904820","title":"Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures \"Outside the Walls\" by Dual Screening Method RTDs and FibroScan®","phase":"","overall_status":"RECRUITING","enrollment_count":2300,"lead_sponsor_name":"University Hospital, Limoges","has_results":false},{"nct_id":"NCT04062253","title":"Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in Madrid","phase":"","overall_status":"COMPLETED","enrollment_count":2001,"lead_sponsor_name":"Hospital Universitario Infanta Leonor","has_results":false},{"nct_id":"NCT07274345","title":"Prevalence and Risk Factors of Antiviral Resistance in Egyptian HBV Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Amira Mohamed Zidan","has_results":false},{"nct_id":"NCT02112890","title":"Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico","phase":"","overall_status":"COMPLETED","enrollment_count":1603,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT05751889","title":"Serious Game Interventions to Reduce Viral Hepatitis C Among PLWH-MSM","phase":"NA","overall_status":"RECRUITING","enrollment_count":1320,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT04470271","title":"Re-linkage to Care of Patients With Hepatitis C","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Austral University, Argentina","has_results":false},{"nct_id":"NCT03537196","title":"DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":979,"lead_sponsor_name":"ANRS, Emerging Infectious Diseases","has_results":false},{"nct_id":"NCT04690972","title":"\"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases\".","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT03854630","title":"Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":575,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT05492565","title":"Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":500,"lead_sponsor_name":"Hospitales Universitarios Virgen del Rocío","has_results":false},{"nct_id":"NCT04304612","title":"A Cost Effective and Time Saving Blood Test to Detect Six Human Bloodborne Infectious Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT05117541","title":"Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Disease Progression Among Korean American With Chronic Hepatitis B Infection","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":365,"lead_sponsor_name":"Thomas Jefferson University","has_results":false},{"nct_id":"NCT04222803","title":"VIRal Hepatitis and GAllstone Disease Study","phase":"","overall_status":"SUSPENDED","enrollment_count":350,"lead_sponsor_name":"Göteborg University","has_results":false},{"nct_id":"NCT05686785","title":"Agreement and Reliability of Transient Elastography","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Lund University","has_results":false},{"nct_id":"NCT03566966","title":"Autoantibodies and Direct-acting Antivirals","phase":"","overall_status":"COMPLETED","enrollment_count":191,"lead_sponsor_name":"University of Bari","has_results":false},{"nct_id":"NCT06859619","title":"Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":183,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT03933384","title":"Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Taichung Veterans General Hospital","has_results":false},{"nct_id":"NCT01639066","title":"Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT03495570","title":"Sysmex-XN 20 Analyser to Assess Lymphocyte Subsets and Other Haematological Parameters in Chronic/Acute Viral Infections","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT06360484","title":"Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus","phase":"","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"National Center for Gastroentestinal and Liver Disease","has_results":false},{"nct_id":"NCT01639092","title":"Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis B","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT03410953","title":"Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León","has_results":true},{"nct_id":"NCT03743272","title":"Repeatability and Reproducibility of Multiparametric MRI","phase":"","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Perspectum","has_results":false},{"nct_id":"NCT03032536","title":"Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":54,"lead_sponsor_name":"Alios Biopharma Inc.","has_results":false},{"nct_id":"NCT07316842","title":"SVR12 in Genotype 3 HCV (F0-F2) Treated With RDV + SOF","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Center of target therapy","has_results":false},{"nct_id":"NCT06564051","title":"Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C","phase":"","overall_status":"TERMINATED","enrollment_count":29,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05683548","title":"Replicor Compassionate Access Program","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Replicor Inc.","has_results":false}],"total":28},"guidelines":[],"source":"Drug Landscape verified database"}